Cost-effectiveness of biomarker-directed toripalimab plus chemotherapy for previously untreated extensive-stage small-cell lung-cancer in China

• Shuo Kang,

  Roles Conceptualization, Data curation, Formal analysis, Methodology, Software

  Affiliation Medical Insurance Office, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, People's Republic of China

  https://orcid.org/0000-0002-8690-4259

  ⨯
• Shan Zhao,

  Roles Data curation, Formal analysis

  Affiliation Department of Oncology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, People's Republic of China

  ⨯
• Xiaohui Wang,

  Roles Data curation, Formal analysis

  Affiliation Development Planning Division, Hebei Medical University, Shijiazhuang, Hebei Province, People's Republic of China

  ⨯
• Zhenhua Pan

  Roles Conceptualization, Methodology

  * E-mail: panzhenhua@hebmu.edu.cn

  Affiliation Development Planning Division, Hebei Medical University, Shijiazhuang, Hebei Province, People's Republic of China

  https://orcid.org/0009-0000-3276-728X

  ⨯